381 related articles for article (PubMed ID: 29712884)
21. Microbiome and Gut Dysbiosis.
Belizário JE; Faintuch J
Exp Suppl; 2018; 109():459-476. PubMed ID: 30535609
[TBL] [Abstract][Full Text] [Related]
22. The gut microbiome and hypertension.
Pevsner-Fischer M; Blacher E; Tatirovsky E; Ben-Dov IZ; Elinav E
Curr Opin Nephrol Hypertens; 2017 Jan; 26(1):1-8. PubMed ID: 27798455
[TBL] [Abstract][Full Text] [Related]
23. A Polysaccharide Isolated from Dictyophora indusiata Promotes Recovery from Antibiotic-Driven Intestinal Dysbiosis and Improves Gut Epithelial Barrier Function in a Mouse Model.
Kanwal S; Joseph TP; Owusu L; Xiaomeng R; Meiqi L; Yi X
Nutrients; 2018 Jul; 10(8):. PubMed ID: 30065236
[TBL] [Abstract][Full Text] [Related]
24. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases.
Lin L; Zhang J
BMC Immunol; 2017 Jan; 18(1):2. PubMed ID: 28061847
[TBL] [Abstract][Full Text] [Related]
25. Gut Microbiota and Heart, Vascular Injury.
Zeng C; Tan H
Adv Exp Med Biol; 2020; 1238():107-141. PubMed ID: 32323183
[TBL] [Abstract][Full Text] [Related]
26. Enteric Pathogens and Their Toxin-Induced Disruption of the Intestinal Barrier through Alteration of Tight Junctions in Chickens.
Awad WA; Hess C; Hess M
Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28208612
[TBL] [Abstract][Full Text] [Related]
27. Antihypertensives and Antibiotics: Impact on Intestinal Dysfunction and Hypertension.
Lucas SE; Walton SL; Mirabito Colafella KM; Mileto SJ; Lyras D; Denton KM
Hypertension; 2023 Jul; 80(7):1393-1402. PubMed ID: 37039016
[TBL] [Abstract][Full Text] [Related]
28. Endocrine organs of cardiovascular diseases: Gut microbiota.
Jia Q; Xie Y; Lu C; Zhang A; Lu Y; Lv S; Zhang J
J Cell Mol Med; 2019 Apr; 23(4):2314-2323. PubMed ID: 30688023
[TBL] [Abstract][Full Text] [Related]
29. Increased Systolic and Diastolic Blood Pressure Is Associated With Altered Gut Microbiota Composition and Butyrate Production in Early Pregnancy.
Gomez-Arango LF; Barrett HL; McIntyre HD; Callaway LK; Morrison M; Dekker Nitert M;
Hypertension; 2016 Oct; 68(4):974-81. PubMed ID: 27528065
[TBL] [Abstract][Full Text] [Related]
30. Citrus flavonoids and the intestinal barrier: Interactions and effects.
Wang M; Zhao H; Wen X; Ho CT; Li S
Compr Rev Food Sci Food Saf; 2021 Jan; 20(1):225-251. PubMed ID: 33443802
[TBL] [Abstract][Full Text] [Related]
31. The gut microbiome and heart failure.
Ahmad AF; Ward NC; Dwivedi G
Curr Opin Cardiol; 2019 Mar; 34(2):225-232. PubMed ID: 30575647
[TBL] [Abstract][Full Text] [Related]
32. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
Halmos T; Suba I
Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
[TBL] [Abstract][Full Text] [Related]
33. Potential Role of the Gut Microbiome in ALS: A Systematic Review.
Wright ML; Fournier C; Houser MC; Tansey M; Glass J; Hertzberg VS
Biol Res Nurs; 2018 Oct; 20(5):513-521. PubMed ID: 29925252
[TBL] [Abstract][Full Text] [Related]
34. Human microbiome and cardiovascular diseases.
Alam MJ; Puppala V; Uppulapu SK; Das B; Banerjee SK
Prog Mol Biol Transl Sci; 2022; 192(1):231-279. PubMed ID: 36280321
[TBL] [Abstract][Full Text] [Related]
35. Intestinal Barrier in Human Health and Disease.
Di Tommaso N; Gasbarrini A; Ponziani FR
Int J Environ Res Public Health; 2021 Dec; 18(23):. PubMed ID: 34886561
[TBL] [Abstract][Full Text] [Related]
36. Gut microbiota in autoimmunity: potential for clinical applications.
Kim D; Yoo SA; Kim WU
Arch Pharm Res; 2016 Nov; 39(11):1565-1576. PubMed ID: 27444041
[TBL] [Abstract][Full Text] [Related]
37. Gut Microbiome in Chronic Kidney Disease.
Armani RG; Ramezani A; Yasir A; Sharama S; Canziani MEF; Raj DS
Curr Hypertens Rep; 2017 Apr; 19(4):29. PubMed ID: 28343357
[TBL] [Abstract][Full Text] [Related]
38. Gut dysbiosis is linked to hypertension.
Yang T; Santisteban MM; Rodriguez V; Li E; Ahmari N; Carvajal JM; Zadeh M; Gong M; Qi Y; Zubcevic J; Sahay B; Pepine CJ; Raizada MK; Mohamadzadeh M
Hypertension; 2015 Jun; 65(6):1331-40. PubMed ID: 25870193
[TBL] [Abstract][Full Text] [Related]
39. Microbiome and Cardiovascular Disease in CKD.
Jovanovich A; Isakova T; Stubbs J
Clin J Am Soc Nephrol; 2018 Oct; 13(10):1598-1604. PubMed ID: 29743160
[TBL] [Abstract][Full Text] [Related]
40. The microbiome as a major function of the gastrointestinal tract and its implication in micronutrient metabolism and chronic diseases.
Lin D; Medeiros DM
Nutr Res; 2023 Apr; 112():30-45. PubMed ID: 36965327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
